← Back
$TBPH All transactions

Theravance Biopharma, Inc.

▼ SELL

$ Value

$146K

Shares

7,767

Price

$19

Filed

Dec 5

Insider

Name

Farnum Rhonda

Title

SVP, COMM & MEDICAL AFFAIRS

CIK

0001898490

Roles

Officer

Transaction Details

Transaction Date

2025-12-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

300,995

Footnotes

This transaction was executed in multiple trades at prices from $18.52 to $18.94 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Filing Info

Accession No.

0001898490-25-000008

Form Type

4

Issuer CIK

0001583107

Farnum Rhonda's History

Date Ticker Type Value
2026-04-01 TBPH A $0
2025-12-03 TBPH $146K
2025-12-03 TBPH $146K
2025-12-03 TBPH $291K
2025-11-20 TBPH F $162K
2025-08-20 TBPH F $122K
2025-07-14 TBPH $8K
2025-07-14 TBPH $61K
2025-07-14 TBPH $46K
2025-06-02 TBPH $264K

Other Insiders at TBPH (90d)

Insider Bought Sold Last
Winningham Rick E
CHIEF EXECUTIVE OFFICER
2026-04-01
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
2026-04-01
Sawaf Aziz
SVP & CHIEF FINANCIAL OFFICER
2026-04-01
Grimaud Brett A.
SVP, GEN COUNSEL AND SECRETARY
2026-04-01